Bill > HB0500

This bill amends the Utah Controlled Substances Act, specifically modifying Section 58-37-4 related to controlled substance schedules. The most significant change involves psilocybin, a hallucinogenic substance traditionally listed in Schedule I. The bill adds a new provision that allows for psilocybin to be rescheduled if the federal government moves it from Schedule I to another schedule, meaning Utah would automatically align its scheduling with federal classification. Additionally, the bill adds two new substances to Schedule III: Amanita Muscaria (a type of mushroom with psychoactive properties) and Nabiximols (a cannabis-based medication). The bill also includes a technical modification to the language around psilocybin, inserting an exception clause. The effective date for these changes is set for May 7, 2025. This modification reflects a growing trend of reassessing the legal status of certain psychoactive substances and potentially creating pathways for medical or research use under regulated conditions.

Health and Social Services

https://le.utah.gov/~2025/bills/static/HB0500.html